Status: current, Defined. Date: 31-Dec 2016. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1754711000168113 | fluorescein sodium 1.25 mg / 0.5 mL + lidocaine hydrochloride monohydrate 20 mg / 0.5 mL eye drops, 20 x 0.5 mL unit doses (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1754721000168118 | lidocaine hydrochloride monohydrate 4% + fluorescein sodium 0.25% eye drops, 20 x 0.5 mL unit doses | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
lidocaine hydrochloride monohydrate 4% + fluorescein sodium 0.25% eye drops, 20 x 0.5 mL unit doses | Is a | medicinal product pack | true | Inferred relationship | Some | ||
lidocaine hydrochloride monohydrate 4% + fluorescein sodium 0.25% eye drops, 20 x 0.5 mL unit doses | has MPUU | lidocaine hydrochloride monohydrate 4% + fluorescein sodium 0.25% eye drops, unit dose | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Lignocaine Hydrochloride 4% and Fluorescein Sodium 0.25% Minims (Bausch & Lomb) eye drops, 20 x 0.5 mL unit doses | Is a | True | lidocaine hydrochloride monohydrate 4% + fluorescein sodium 0.25% eye drops, 20 x 0.5 mL unit doses | Inferred relationship | Some |
Reference Sets
Medicinal product pack reference set